Is capecitabine a cost-effective adjuvant treatment of stage III colon cancer in Ontario?

被引：0
|
作者：
Orchard, M. C. [1 ]
Hoch, J. S. [1 ]
Alibhai, S. M. [1 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15024
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Survival Impact of CAPOX Versus FOLFOX in the Adjuvant Treatment of Stage III Colon Cancer
    Loree, Jonathan M.
    Sha, Aaron
    Soleimani, Maryam
    Kennecke, Hagen F.
    Ho, Maria Y.
    Cheung, Winson Y.
    Mulder, Karen E.
    Abadi, Shirin
    Spratlin, Jennifer L.
    Gill, Sharlene
    CLINICAL COLORECTAL CANCER, 2018, 17 (02) : 156 - 163
  • [42] Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An Underused Lifesaving Treatment
    Muss, Hyman B.
    Bynum, Debra L.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) : 2576 - 2578
  • [43] Pilot study of the combination of capecitabine plus oxaliplatin as adjuvant therapy for patients with stage III and high risk stage II colon cancer
    Olier, C.
    Reyna, C.
    Aramendia, J. M.
    Rodriguez, J.
    Viudez, A.
    Chopitea, A.
    Garcia-Foncillas, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [44] Cost-Effectiveness of Adjuvant Chemotherapy in the Treatment of Early-Stage Colon Cancer
    Soni, Amy
    Chu, Edward
    CLINICAL COLORECTAL CANCER, 2015, 14 (04) : 219 - 226
  • [45] Pharmacoeconomic Analysis of Capecitabine versus 5-Fluorouracil/Leucovorin as Adjuvant Therapy for Stage III Colon Cancer in Taiwan
    Hsu, Tzu-Chi
    Chen, Hong-Hwa
    Yang, Ming-Chin
    Wang, Hwei-Ming
    Chuang, Jye-Hann
    Jao, Shu-Wen
    Chiang, Hsin-Chieh
    Wen, Chung-Yu
    Tseng, Jen-Hao
    Chen, Li-Tzong
    VALUE IN HEALTH, 2011, 14 (05) : 647 - 651
  • [46] Compliance with adjuvant capecitabine in patients with stage II and III colon cancer: comparison of administrative versus medical record data
    Amlani, Adam
    Kumar, Aalok
    Ruan, Jenny Y.
    Cheung, Winson Y.
    CANCER MEDICINE, 2016, 5 (08): : 1776 - 1782
  • [47] Final report of KSCC0803: feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japan
    Minami, Kazuhito
    Morita, Masaru
    Emi, Yasunori
    Okamoto, Masahiro
    Tanaka, Eiji
    Nagata, Shigeyuki
    Touyama, Tetsuo
    Ohgaki, Kippei
    Tanaka, Takaho
    Okumura, Hiroshi
    Suenaga, Toyokuni
    Tokunaga, Shoji
    Oki, Eiji
    Kakeji, Yoshihiro
    Akagi, Yoshito
    Baba, Hideo
    Natsugoe, Shoji
    Maehara, Yoshihiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (03) : 505 - 510
  • [48] Cost-effectiveness of 12 months of capecitabine as adjuvant chemotherapy for stage III colon cancer: preplanned cost-effectiveness analysis of the JFMC37-0801 study
    Shibahara, Hidetoshi
    Shiroiwa, Takeru
    Ishiguro, Megumi
    Nakamura, Masato
    Hasegawa, Junichi
    Yamaguchi, Shigeki
    Masuda, Yuriko
    Sakamoto, Junichi
    Tomita, Naohiro
    Fukuda, Takashi
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2022, 23 (07): : 1159 - 1171
  • [49] Cost-effectiveness of 12 months of capecitabine as adjuvant chemotherapy for stage III colon cancer: preplanned cost-effectiveness analysis of the JFMC37-0801 study
    Hidetoshi Shibahara
    Takeru Shiroiwa
    Megumi Ishiguro
    Masato Nakamura
    Junichi Hasegawa
    Shigeki Yamaguchi
    Yuriko Masuda
    Junichi Sakamoto
    Naohiro Tomita
    Takashi Fukuda
    The European Journal of Health Economics, 2022, 23 : 1159 - 1171
  • [50] Final report of KSCC0803: feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japan
    Kazuhito Minami
    Masaru Morita
    Yasunori Emi
    Masahiro Okamoto
    Eiji Tanaka
    Shigeyuki Nagata
    Tetsuo Touyama
    Kippei Ohgaki
    Takaho Tanaka
    Hiroshi Okumura
    Toyokuni Suenaga
    Shoji Tokunaga
    Eiji Oki
    Yoshihiro Kakeji
    Yoshito Akagi
    Hideo Baba
    Shoji Natsugoe
    Yoshihiko Maehara
    International Journal of Clinical Oncology, 2017, 22 : 505 - 510
12345